Palliation in heart failure: When less and more are more

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Hauptman, P. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hauptman, P. J.


Social Bookmarking

	What's this?

Paul J. Hauptman, MD

Paul J. Hauptman, MD, Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, St. Louis, Missouri

References

1. Croft JB, Giles WH, Pollard RA, et al.: Heart failure survival among older adults in the United States. Arch Int Med. 1999; 159: 505-510.[Abstract/Free Full Text]

2. Ho KKL, Anderson KM, Kannel WB, et al.: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993; 107-115.

3. Gillum RF: Epidemiology of heart failure in the United States. Am Heart J. 1993; 126: 1042-1047.[CrossRef][Medline] [Order article via Infotrieve]

4. Flather MD, Yusuf S, Kuber L, et al.: Long-term ACE inhibitor therapy in patients with heart failure or left ventricular dysfunction: A systematic overview of data from individual patients. Lancet. 2000; 355: 1575-1581.[CrossRef][Medline] [Order article via Infotrieve]

5. Metra M, Nodari S, D'Aloia A, et al.: A rationale for the use of beta-blockers as standard treatment for heart failure. Am Heart J. 2000; 139: 511-521[Medline] [Order article via Infotrieve]

6. Baker DW, Einstadter D, Thomas C, et al.: Mortality trends for 23,505 Medicare patients hospitalized with heart failure in northeast Ohio, 1991-1997. Am Heart J. 2003; 146: 258-264.[CrossRef][Medline] [Order article via Infotrieve]

7. Heiat A, Gross CP, Krumholz HM: Representation of the elderly, women and minorities in heart failure clinical trials. Arch Int Med 2002; 162: 1682-1688.[Abstract/Free Full Text]

8. Masoudi FA, Havranek EP, Wolf P, et al.: Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003; 146: 250-257.[CrossRef][Medline] [Order article via Infotrieve]

9. Hosenpud J: Immunosuppression in cardiac transplantation. N Engl J Med. 2005; 352: 2749-2750.[Free Full Text]

10. Rose E, Gelijns A, Moskowitz A: Long term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001; 345: 1435-1443.[Abstract/Free Full Text]

11. Mehra M, Greenberg B: Caveat medicus! J Am Coll Cardiol. 2004; 43: 1145-1148.[Abstract/Free Full Text]

12. Hauptman PJ, Rector T, Wentworth D, et al.: Quality of life in advanced heart failure: Role of mitral regurgitation. Am Heart J. in press. 2006; 151: 213-218.[CrossRef][Medline] [Order article via Infotrieve]

13. Masoudi FA, Rumsfeld JS, Havranek EP, et al.: Age, functional capacity and health related quality of life in patients with heart failure. J Card Fail. 2004; 10: 368-373.[CrossRef][Medline] [Order article via Infotrieve]

14. Rabow MW, Dibble SL, Pantilat SZ, et al.: The Comprehensive Care Team: A randomized trial of outpatient palliative medicine consultation. Arch Int Med 2004; 164: 83-91.[Abstract/Free Full Text]

15. Hauptman PJ, Havranek EP: Integrating palliative care into heart failure care. Arch Int Med. 2005; 165: 374-378.[Abstract/Free Full Text]

16. Hunt SA, Baker DW, Chin MH, et al.: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at: http./www.acc.orgclinicallguidelineslfailurelhfindex.htm.

17. Ewy GA: Inotropic infusions for chronic congestive heart failure: Medical miracles or misguided medicinals? J Am Coll Cardiol. 1999; 33: 572-575.[Free Full Text]

18. Mikolajczak P, George A, Oliver D, et al.: Preliminary economic analysis of chronic continuous home inotropic therapy in end-stage heart failure: Insights from a multi-state Medicare database. J Card Fail. 2004; 10: S109-S109.

19. Rich MW, Shore BL: Dobutamine for patients with end-stage heart failure in a hospice program. J Palliat Med. 2003; 6: 93-97.[CrossRef][Medline] [Order article via Infotrieve]

20. Kutner J, Goodlin SJ, Connor SR, et al.: Hospice care for heart failure patients. J Pain Sympt Mgmt. 2005; 29: 525-528.[CrossRef]

21. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346: 877-883.[Abstract/Free Full Text]

22. Bardy GH: Amiodarone or implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.[Abstract/Free Full Text]

23. Goldstein NE, Lampert R, Bradley E, et al.: Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004; 141: 835-838.[Abstract/Free Full Text]

24. Jaagosild P, Dawson NV, Thomas C, et al. for the SUPPORT Investigators: Outcomes of acute exacerbation of severe congestive heart failure: Quality of life, resource use and survival: The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatment. Arch Int Med. 1998; 158: 1081-1089.[Abstract/Free Full Text]

25. Krumholz HM, Phillips RS, Hamel MB, et al., for the SUPPORT Investigators: Resuscitation preferences among patients with severe congestive heart failure: Results from the SUPPORT project. Circulation. 1998; 98: 648-655.[Abstract/Free Full Text]